Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESCAPE: AZD5672 in Rheumatoid Arthritis
NCT00713544Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Jul 2008
- Primary completion
- Apr 2009
- Modality
- Small Molecules
- Countries
- 14
01
Overview
A Phase 2 trial of azd5672 in rheumatoid arthritis (RA), sponsored by AstraZeneca. Started Jul 2008; status: completed.
02
Drugs
azd5672
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00713544.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00713544.